In January 2021, according to a World Health Organization report, cancer became the major cause of death in 2020, with 10 million in approximation, where often cases were of breast cancer (2.26 million), lung (2.21 million), colon and rectum (1.93 million); prostate (1.41 million), skin (1.20 million) and stomach (1.09 million). In September 2020, according to ACS Journal, 19.3 million new cancer cases were recorded, with 9.9 million deaths through cancer (excluding non-melanoma).
Access Full Report at https://www.databridgemarketresearch.com/reports/global-flow-cytometry-market
The global flow cytometry market is expected to reach USD 11,016.73 Million by 2029 from USD 4,741.84 Million in 2021, growing at a CAGR of 11.2% in the forecast period of 2022 to 2029. The increase in the adoption of flow cytometry in research and academia and wide development in pharmaceutical and biotechnology industries are expected to drive the market's growth. The developing pipeline of stem cell research and strategic initiatives by market players are expected to provide an opportunity to enhance the treatment.
The increasing prevalence of chronic diseases across the world will drive the market's growth rate
The increasing prevalence and incidences of chronic diseases are likely to drive market growth by focusing on cytometry devices. The rising incidence of diseases increases the global market as many companies invest in research and development. This resulted in the huge lead in demand for advancements to diagnose the disease through quick and accurate techniques. Hence, the rising prevalence of chronic diseases and the growing demand for advanced diagnostic techniques can aid the numerous research studies for the market's rapid growth.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2022 to 2029
|
Base Year
|
2021
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
Segments Covered
|
Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories and Services), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank and Others), Distribution Channel (Direct Tenders and Retail Sales)
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
Market Players Covered
|
Sysmex Corporation (Japan), Agilent Technologies, Inc. (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Luminex Corporation (U.S.), Sony Biotechnology Inc. (U.S.), Apogee Flow Systems Ltd. (U.K.), Cytek Biosciences (U.S.), bioMérieux SA (France), Merck KGaA (Germany), Elabscience Biotechnology Inc. (U.S.), Miltenyi Biotec (Germany), Takara Bio Inc. (Japan), Thermo Fisher Scientific Inc. (U.S.), Q2 Solutions (U.S.)., CellKraft Biotech Pvt. Ltd. (India), Sartorius AG (Germany), NeoGenomics Laboratories (U.S.) among others.
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global flow cytometry market is categorized into five notable segments based on product, technology, application, end user, and distribution channel.
The pharmaceutical & biotechnology companies segment will dominate the end user segment of the flow cytometry market
The pharmaceutical & biotechnology companies segment will emerge as the dominating segment under end user with approximately 35.00% market share. This is because of the growing number of infrastructural development activities in the market especially in the developing economies. Further, growth and expansion of the IT industry all around the globe will further bolster the growth of this segment.
The retail sales segment will dominate the distribution channel segment of the flow cytometry market
The retail sales segment will emerge as the dominating segment distribution channel segment. This is because of the growing number of retailers in the market especially in the developing economies. Further, growth and expansion of research development services on a global scale will further bolster the growth of this segment.
Major Players
Data Bridge Market Research recognizes the following companies as the market players in flow cytometry market: Sysmex Corporation (Japan), Agilent Technologies, Inc. (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Luminex Corporation (U.S.), Sony Biotechnology Inc. (U.S.), Apogee Flow Systems Ltd. (U.K.), Cytek Biosciences (U.S.), bioMérieux SA (France), Merck KGaA (Germany), Elabscience Biotechnology Inc. (U.S.), Miltenyi Biotec (Germany), Takara Bio Inc. (Japan), Thermo Fisher Scientific Inc. (U.S.), Q2 Solutions (U.S.)., CellKraft Biotech Pvt. Ltd. (India), Sartorius AG (Germany), NeoGenomics Laboratories (U.S.).
Market Development
Regional Analysis
Geographically, the countries covered in the flow cytometry market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in the flow cytometry market during the forecast period 2022 - 2029
North America is expected to dominate the global flow cytometry market due to the technological advancement and growing adoption of various advanced diagnostic applications.
Asia-Pacific is estimated to be the fastest growing region in the flow cytometry market the forecast period 2022 - 2029
Asia-Pacific is likely to be the fastest-growing region in the global market owing to the developing healthcare infrastructure.
COVID-19 Impact
According to an interview with Thermo Fisher Scientific (US) scientists, the University of California requested participants for a significant project researching the impacts of SARS-CoV-2 from researchers, nurses, and doctors. Using other flow cytometry analyzers, such as the Attune NxT Flow Cytometer, the researchers analyzed blood samples using purified proteins and antibody panels. Since several COVID-19 research projects use flow cytometry technologies to examine how the immune system responds to SARS-CoV-2, the COVID-19 pandemic has thus had a favorable effect on this industry.
For more detailed information about the flow cytometry on market report, click here – https://www.databridgemarketresearch.com/reports/global-flow-cytometry-market
Global Flow Cytometry Market – Industry Trends and Forecast to 2029
North America Flow Cytometry Market – Industry Trends and Forecast to 2029
Europe Flow Cytometry Market – Industry Trends and Forecast to 2029
France Flow Cytometry Market – Industry Trends and Forecast to 2029
Middle East and Africa Flow Cytometry Market – Industry Trends and Forecast to 2029
Asia-Pacific Flow Cytometry Market – Industry Trends and Forecast to 2029
BD, Merck KGaA, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc, bioMérieux SA and others are dominating the market for France Flow Cytometry Market in 2017
Thermo Fisher Scientific, Inc., BD, Agilent Technologies, Inc. dominated the Asia-Pacific Flow Cytometry Market in 2022